COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017

Feb 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-01-31

Reporting Person: Heffernan Michael Thomas (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-27	Common Stock	A	1239	$10.08	Acquired	552542	Direct
2017-01-31	Common Stock	M	3013	$.48	Acquired	555555	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-31	Stock Option (Right to Purchase)	$.48	M	3013	Disposed	2023-01-30	Common Stock (3013)	Direct

Footnotes

F1: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: All of the 3,013 option shares are exercisable.